Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome?

Although the benefits of next-generation sequencing (NGS) for the diagnosis of heterogeneous diseases such as intellectual disability (ID) are undisputed, there is little consensus on the relative merits of targeted enrichment, whole-exome sequencing (WES) or whole-genome sequencing (WGS). To answer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yu Sun, Claudia Ruivenkamp, Mariëtte J.V. Hoffer, Terry Vrijenhoek, Marjolein Kriek, Christi J. van Asperen, Johan T. den Dunnen, Gijs W.E. Santen
Format: Artigo
Sprache:Englisch
Veröffentlicht: 2015
Online-Zugang:https://doi.org/10.1002/humu.22783
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!